Sanofi-Aventis sues Novopharm for patent infringement in Canada

16-Mar-2005

Sanofi-aventis has learned through the Canadian Ministry of Health website that Novopharm Limited has obtained marketing approval in Canada for a product claiming to be generic enoxaparin.

Sanofi-aventis companies Aventis Pharma Inc. and Aventis Pharma S.A. are bringing suit in the Federal Court against Novopharm for patent infringement of Canadian patent 2045433, which covers Lovenox®.

Sanofi-aventis will vigorously defend its legal rights with respect to this patent.

Other news from the department politics & laws

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance